These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35235702)

  • 1. Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice.
    O'Bryant SE; Petersen M; Hall J; Johnson LA;
    Alzheimers Dement; 2023 Jan; 19(1):36-43. PubMed ID: 35235702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD).
    Yu F; Pituch KA; Maxfield M; Baena E; Geda YE; Pruzin JJ; Coon DW; Shaibi GQ;
    PLoS One; 2024; 19(4):e0295749. PubMed ID: 38558059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau.
    Janelidze S; Palmqvist S; Leuzy A; Stomrud E; Verberk IMW; Zetterberg H; Ashton NJ; Pesini P; Sarasa L; Allué JA; Teunissen CE; Dage JL; Blennow K; Mattsson-Carlgren N; Hansson O
    Alzheimers Dement; 2022 Feb; 18(2):283-293. PubMed ID: 34151519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men.
    Gillespie NA; Elman JA; McKenzie RE; Tu XM; Xian H; Reynolds CA; Panizzon MS; Lyons MJ; Eglit GML; Neale MC; Rissman RA; Franz C; Kremen WS
    Alzheimers Dement; 2024 Jan; 20(1):356-365. PubMed ID: 37622539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated C-Reactive Protein in Older Men With Chronic Pain: Association With Plasma Amyloid Levels and Hippocampal Volume.
    Bell TR; Franz CE; Thomas KR; Williams ME; Eyler LT; Lerman I; Fennema-Notestine C; Puckett OK; Dorros SM; Panizzon MS; Pearce RC; Hagler DJ; Lyons MJ; Elman JA; Kremen WS
    J Gerontol A Biol Sci Med Sci; 2024 Nov; 79(11):. PubMed ID: 39169831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pre-analytical sample handling factors on plasma biomarkers of Alzheimer's disease.
    Kurz C; Stöckl L; Schrurs I; Suridjan I; Gürsel SÜ; Bittner T; Jethwa A; Perneczky R
    J Neurochem; 2023 Apr; 165(1):95-105. PubMed ID: 36625424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease.
    Leuzy A; Cullen NC; Mattsson-Carlgren N; Hansson O
    Curr Opin Neurol; 2021 Apr; 34(2):266-274. PubMed ID: 33470669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Biomarkers of Alzheimer's Disease Are Associated with Physical Functioning Outcomes Among Cognitively Normal Adults in the Multiethnic HABS-HD Cohort.
    O'Bryant SE; Petersen M; Hall JR; Large S; Johnson LA;
    J Gerontol A Biol Sci Med Sci; 2023 Jan; 78(1):9-15. PubMed ID: 35980599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Physiological Variables and Comorbidities on Plasma Aβ40, Aβ42, and p-tau181 Levels in Cognitively Unimpaired Individuals.
    Martínez-Dubarbie F; Guerra-Ruiz A; López-García S; Irure-Ventura J; Lage C; Fernández-Matarrubia M; Pozueta-Cantudo A; García-Martínez M; Corrales-Pardo A; Bravo M; Martín-Arroyo J; Infante J; López-Hoyos M; García-Unzueta MT; Sánchez-Juan P; Rodríguez-Rodríguez E
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals.
    Sun Q; Ni J; Wei M; Long S; Li T; Fan D; Lu T; Shi J; Tian J
    Front Aging Neurosci; 2022; 14():963845. PubMed ID: 36062146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
    Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C
    J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
    Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
    ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.
    Brickman AM; Manly JJ; Honig LS; Sanchez D; Reyes-Dumeyer D; Lantigua RA; Lao PJ; Stern Y; Vonsattel JP; Teich AF; Airey DC; Proctor NK; Dage JL; Mayeux R
    Alzheimers Dement; 2021 Aug; 17(8):1353-1364. PubMed ID: 33580742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of cerebrospinal fluid biomarkers in Alzheimer's disease.
    Peña-Bautista C; Álvarez-Sánchez L; Pascual R; Moreno MJ; Baquero M; Cháfer-Pericás C
    Eur J Clin Invest; 2023 Mar; 53(3):e13910. PubMed ID: 36401799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases.
    Seino Y; Nakamura T; Kawarabayashi T; Hirohata M; Narita S; Wakasaya Y; Kaito K; Ueda T; Harigaya Y; Shoji M
    J Alzheimers Dis; 2019; 68(1):395-404. PubMed ID: 30814356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans.
    Moon S; Kim S; Mankhong S; Choi SH; Vandijck M; Kostanjevecki V; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Kim HJ; Jang JW; Hong JY; Park DH; Shaw LM; Kang JH
    Alzheimers Res Ther; 2021 Jan; 13(1):22. PubMed ID: 33436035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers.
    Howell JC; Watts KD; Parker MW; Wu J; Kollhoff A; Wingo TS; Dorbin CD; Qiu D; Hu WT
    Alzheimers Res Ther; 2017 Nov; 9(1):88. PubMed ID: 29096697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease related biomarkers in bipolar disorder - A longitudinal one-year case-control study.
    Knorr U; Simonsen AH; Jensen CS; Zetterberg H; Blennow K; Akhøj M; Forman J; Hasselbalch SG; Kessing LV
    J Affect Disord; 2022 Jan; 297():623-633. PubMed ID: 34728295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.